224 related articles for article (PubMed ID: 37537652)
1. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer.
Zhu M; Li S; Yuan L; Liu S; Li J; Zhang D; Chen J; Jiang J; Xu Z
World J Surg Oncol; 2023 Aug; 21(1):238. PubMed ID: 37537652
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.
Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
4. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
5. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
[TBL] [Abstract][Full Text] [Related]
6. Preoperative radiation may improve the outcomes of resectable IIIA/N2 non-small-cell lung cancer patients: A propensity score matching-based analysis from surveillance, epidemiology, and end results database.
Chen D; Wang H; Song X; Yue J; Yu J
Cancer Med; 2018 Sep; 7(9):4354-4360. PubMed ID: 30058192
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
[TBL] [Abstract][Full Text] [Related]
8. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
9. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
10. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.
Jin X; Chen D; Shen Y; Shu J; Sang Y; Yang W; Duan S; Chen Y
Thorac Cancer; 2022 Oct; 13(19):2767-2775. PubMed ID: 36054738
[TBL] [Abstract][Full Text] [Related]
11. Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database.
Wang X; Song J; Long J; Zeng Z; Liu A
Radiat Oncol; 2021 Sep; 16(1):184. PubMed ID: 34544464
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.
Dai H; Hui Z; Ji W; Liang J; Lu J; Ou G; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; He J; Wang L
Oncologist; 2011; 16(5):641-50. PubMed ID: 21482587
[TBL] [Abstract][Full Text] [Related]
15. The Value of Radiotherapy in Patients With Resectable Stage IIIA Non-Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis.
Liu B; Wang Z; Zhao H; Gao S; Wang H; Zhang Y; Fan K; Tao R; Li Y; Feng J; Sun Y; Zhang J; Zhang G
Clin Lung Cancer; 2023 Jan; 24(1):18-28. PubMed ID: 36446703
[TBL] [Abstract][Full Text] [Related]
16. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
17. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
Gao F; Li N; Xu Y; Yang G
J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
[TBL] [Abstract][Full Text] [Related]
18. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
[TBL] [Abstract][Full Text] [Related]
19. Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non-small cell lung cancer: A population-based study.
Xu L; Xie HN; Chen XK; Bi N; Qin JJ; Li Y
Thorac Cancer; 2021 Mar; 12(6):760-767. PubMed ID: 33481353
[TBL] [Abstract][Full Text] [Related]
20. Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysis.
Kou P; Wang H; Lin J; Zhang Y; Yu J
Future Oncol; 2018 Oct; 14(23):2371-2381. PubMed ID: 29807451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
